Drug intelligence / Profile preview

agave sisalana fiber + flaxseed + corchorus capsularis fiber + tobacco leaf

Development stage
Approved
Lead developer
Nelco Laboratories
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

Agave sisalana fiber + flaxseed + corchorus capsularis fiber + tobacco leaf is a combination allergenic extract used for the diagnosis and treatment of specific allergies. [24] It contains allergenic proteins and other molecules derived from sisal fiber, flaxseed, jute (Corchorus capsularis) fiber, and tobacco leaf. As a diagnostic tool, it is applied via skin tests to identify sensitization by observing the resulting wheal-and-flare reaction. [24, 25] For therapeutic purposes, known as allergen immunotherapy or hyposensitization, it is administered in gradually increasing doses, typically through subcutaneous injections. [24, 27] This process aims to modulate the patient's immune system, shifting it from a Th2-mediated allergic reaction towards a state of tolerance, thereby reducing or eliminating allergic symptoms upon natural exposure to these allergens. [27] The use of such extracts is an established treatment for allergic diseases like allergic rhinitis when avoidance is not possible. [27]

Other names
flaxseed + tobacco leaf + corchorus capsularis fiber + agave sisalana fiber
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on agave sisalana fiber + flaxseed + corchorus capsularis fiber + tobacco leaf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on agave sisalana fiber + flaxseed + corchorus capsularis fiber + tobacco leaf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call